#in vivo gene editing

CRISPR Therapy Breakthrough 2026: One-Shot Cure

The first Phase 3 trial of in-body CRISPR therapy shows an 87% reduction in attacks. Could this one-shot cure end genetic disease forever? Read the deep-dive analysis.